Tivic Health Systems is developing immune‑modulating therapies for conditions, such as radiation exposure, while expanding ...
The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...
Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
For decades, radiation oncology advanced incrementally, improving precision through software and delivery techniques while ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Claflin University is building a biotech innovation center to offer students hands-on experiences in emerging fields, backed by $17 million in federal funding.
Microbial biotechnology is a dynamic field, The origins of microbiology can be traced back to the pioneering research by scientists such as Louis Pasteur and Robert Koch in the 19 th century. Within a ...
Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...
"Biotechnology" is a term commonly applied to the development of new medicines and therapies, the development of genetically modified plants, biofuels, biological treatment, or the production of ...
The average one-year price target for Vir Biotechnology (NasdaqGS:VIR) has been revised to $20.74 / share. This is an increase of 26.10% from the prior estimate of $16.45 dated February 21, 2026. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results